| http://www.w3.org/ns/prov#value | - The team from the university's Cancer Science Institute of Singapore (CSI Singapore) suspect that a previously known drug called a PARP inhibitor, normally used to treat only types of cancer that cause damaged DNA, will prove effective in treating leukaemia when used together with standard chemotherapy drugs.
|
